Filing Details
- Accession Number:
- 0001127602-20-013895
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-16 17:00:46
- Reporting Period:
- 2020-04-15
- Accepted Time:
- 2020-04-16 17:00:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1682852 | Moderna Inc. | MRNA | Biological Products, (No Disgnostic Substances) (2836) | 813467528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1760670 | Juan Andres | C/O Moderna, Inc. 200 Technology Square Cambridge MA 02139 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-04-15 | 23,403 | $12.21 | 23,403 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-04-15 | 4,607 | $36.04 | 18,796 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-15 | 8,852 | $36.91 | 9,944 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-15 | 9,944 | $37.78 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-04-15 | 23,403 | $0.00 | 23,403 | $12.21 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 837,322 | 2027-08-29 | No | 4 | M | Direct |
Footnotes
- The reported transaction was effected pursuant to a Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.31 to $36.29. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.32 to $37.32. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.33 to $38.29. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- 25% of this option vested and became exercisable on August 1, 2018 with the remainder vesting in 12 equal quarterly installments thereafter.
Billionaire Hedge Funds
